secwatch / observer
8-K filed September 11, 2025, 7:59 PM ET ticker CYPH CIK 0001509745
regulatory confidence high sentiment negative materiality 0.65

CYPHERPUNK TECHNOLOGIES INC. (CYPH): Nasdaq/NYSE listing notice — Leap Therapeutics gets Nasdaq bid price extension to March 9, 2026

CYPHERPUNK TECHNOLOGIES INC.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.82

CYPHERPUNK TECHNOLOGIES INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange
nasdaq
Notice
delisting notice
Deficiency
minimum bid price
Rules
5550(a)(2)
Exact text from the filing
September 8, 2025, to regain compliance with Rule 5550(a)(2) by maintaining a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. Additionally, Nasdaq notified the Company that it might be eligible for an additional compliance period of 180 calendar days if, on September 8, 2025, the Company met the continued listing requirement for market value of publicly held shares and all other applicable standards for initial listing on the Nasdaq Capital Market (with the exception of the closing bid price requirement) based on the Company’s then most recent publi
View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

CYPHERPUNK TECHNOLOGIES INC. filing history →

Source: SEC EDGAR
accession 0001410578-25-002072
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.